In this webinar, expert panelists from Gilead Sciences, Illumina, Loxo Oncology, and Taiho Oncology explore the utility of comprehensive Genomic Landscapes for precision medicine in oncology. Drawing on a wealth of experience in the oncology CDx space, our speakers highlight the current applications, upcoming trends, and future challenges of CDx development in the modern precision medicine era.
Moderated by CSO Dr. Mark Kiel.
Contact us at hello@genomenon.com to learn more.
